A new imaging technology combines laser pulses with ultrasound detection for high-resolution 3D vascular imaging through the skin. The portable hardware from Helmholtz Munich and TUM could open up a new market for non-invasive diagnostic devices.
A new imaging technology makes it possible to detect early signs of heart disease through the skin. This opens up new markets for portable imaging systems.
Cardiovascular diseases are the most common cause of death worldwide, but their early detection remains one of the greatest challenges of modern medicine. While conventional diagnostic procedures such as ECG or echocardiography can only detect major structural changes or acute events, cardiovascular diseases begin at the microvascular level—in the smallest blood vessels. These early changes have so far remained invisible to non-invasive imaging and require expensive, complex examination procedures. At the same time, there is growing pressure on electronics developers to develop cost-effective, portable diagnostic systems that enable precise early detection outside of specialized clinics. In this area of conflict, a new optoacoustic technology is positioning itself as a potential solution.
Laser Pulses Become Ultrasonic Waves
The core of "Fast-RSOM" (Raster-Scan-Optoacoustic Mesoscopy) is based on an elegant physical principle: short laser pulses heat tissue minimally, causing it to expand and generate ultrasound waves. These are recorded by highly sensitive ultrasound detectors and processed into 3D images. Unlike pure ultrasound or optical procedures, RSOM combines the advantages of both modalities and thus achieves high contrast with deep penetration into individual skin layers and capillaries.
The fast variant optimizes this technology for real-time applications. Dr. Hailong He from the Institute of Biological and Medical Imaging explains: "With fast-RSOM, we have succeeded for the first time in non-invasively recording endothelial function in humans by resolving individual capillaries." This capability opens up completely new possibilities for the early detection of cardiovascular disease, as the technology can detect subtle changes in microvascular endothelial dysfunction (MiVED) long before clinical symptoms appear.
Complex Data Processing
The originally laboratory-based RSOM system had to be completely redesigned for clinical use, which posed considerable technical challenges for electronics developers. The integration of compact, stable laser systems for reproducible pulse generation was just as demanding as the development of high-resolution ultrasound arrays in a portable format. Real-time signal processing for image reconstruction from optoacoustic data and thermal management for reliable laser performance in a compact design proved to be particularly critical.
However, the biggest technical challenge lies in data processing: high-resolution 3D images with single capillary resolution must be calculated in real time from the raw optoacoustic data. The optimized software not only performs image reconstruction, but also calculates dynamic biomarkers for MiVED—quantitative parameters that can detect subtle vascular changes. The result is a portable system that is "fast and non-invasive" and could even be used in outpatient clinics.
Alternative to Stationary Imaging Systems
This opens up a wide range of market potential for electronics developers. The technology could represent an alternative to expensive, stationary imaging systems and open up new fields of application in preventive medicine, therapy monitoring and point-of-care diagnostics. Prof. Vasilis Ntziachristos, Director of the Bioengineering Center at Helmholtz Munich, sees enormous potential: "Through earlier interventions and more precise monitoring, fast-RSOM could fundamentally change the prevention and treatment of cardiovascular diseases."
However, the path from basic research to a market-ready product still faces considerable challenges. The research team is initially planning validation in larger patient studies and the integration of biomarkers into clinical workflows. At the same time, aspects such as medical approval in accordance with the Medical Devices Act, cost optimization for practical suitability and standardization of measurement protocols must be mastered.
The functional principle of RSOM technology uses laser pulses in the nanosecond range that hit tissue and generate ultrasound waves through thermoelastic expansion. These waves carry information about tissue properties such as blood content, oxygen saturation and vascular architecture. The unique selling points include a penetration depth of several inches at microscopic resolution, natural contrast through haemoglobin without contrast agent, real-time imaging and complete safety through non-ionizing, non-invasive procedures.
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
New Device Category in Medical Technology
Fast-RSOM is an example of how established technologies can open up completely new fields of application through sophisticated combinations. For electronics developers, this opens up an expanding market for portable, high-resolution imaging systems beyond classic ultrasound or X-ray technology. The next few years will show whether optoacoustic systems can establish themselves as a new device category in medical technology and thus usher in a further technological revolution in medical diagnostics. (heh)